Aeterna Zentaris Reports Q4 Loss, Tops Revenue Estimates
AEZSDelisted Stock | USD 6.14 0.08 1.29% |
Slightly above 62% of AEZS Old's investor base is looking to short. The analysis of current outlook of investing in AEZS Old suggests that many traders are alarmed regarding AEZS Old's prospects. AEZS Old's investing sentiment can be driven by a variety of factors including economic data, AEZS Old's earnings reports, geopolitical events, and overall market trends.
AEZS |
Aeterna Zentaris delivered earnings and revenue surprises of 9.68 percent and 134.43, respectively, for the quarter ended December 2022. Do the numbers hold clues to what lies ahead for the stock
Read at zacks.com
AEZS Old Fundamental Analysis
We analyze AEZS Old's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of AEZS Old using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of AEZS Old based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Short Ratio
Short Ratio Comparative Analysis
AEZS Old is currently under evaluation in short ratio category among its peers. Short Ratio is typically used by traders and speculators to identify trends in current market sentiment for a particular equity instrument. In its simple terms this ratio shows how many days it will take all current short sellers to cover their positions if the price of a stock begins to rise.
AEZS Old Potential Pair-trading
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with AEZS Old stock to make a market-neutral strategy. Peer analysis of AEZS Old could also be used in its relative valuation, which is a method of valuing AEZS Old by comparing valuation metrics with similar companies.
Peers
AEZS Old Related Equities
RNAZ | Transcode Therapeutics | 24.64 | ||||
PULM | Pulmatrix | 11.13 | ||||
ATXI | Avenue Therapeutics | 8.09 | ||||
TNXP | Tonix Pharmaceuticals | 1.84 | ||||
IBIO | Ibio | 0.98 | ||||
ADTX | Aditxt | 0.91 | ||||
ADIL | Adial Pharmaceuticals | 0 | ||||
RVPH | Reviva Pharmaceuticals | 0.52 | ||||
MBRX | Moleculin Biotech | 0.57 | ||||
JAGX | Jaguar Animal | 1.33 | ||||
BPTH | Bio Path | 4.02 |
Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in nation. You can also try the Price Transformation module to use Price Transformation models to analyze the depth of different equity instruments across global markets.
Other Consideration for investing in AEZS Stock
If you are still planning to invest in AEZS Old check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the AEZS Old's history and understand the potential risks before investing.
Pair Correlation Compare performance and examine fundamental relationship between any two equity instruments | |
CEOs Directory Screen CEOs from public companies around the world | |
Volatility Analysis Get historical volatility and risk analysis based on latest market data | |
Portfolio Anywhere Track or share privately all of your investments from the convenience of any device | |
Competition Analyzer Analyze and compare many basic indicators for a group of related or unrelated entities | |
Analyst Advice Analyst recommendations and target price estimates broken down by several categories | |
Portfolio Suggestion Get suggestions outside of your existing asset allocation including your own model portfolios | |
Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope | |
Funds Screener Find actively-traded funds from around the world traded on over 30 global exchanges |